PHOTON ENERGY NV (P7V.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:P7V - NL0010391108 - Common Stock
0.425 EUR
-0.03 (-5.56%)
We assign a fundamental rating of 3 out of 10 to P7V. P7V was compared to 73 industry peers in the Electrical Equipment industry. P7V has a bad profitability rating. Also its financial health evaluation is rather negative. P7V is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
- In the past year P7V has reported negative net income.
- In the past year P7V had a positive cash flow from operations.
- In the past 5 years P7V reported 4 times negative net income.
- P7V had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- The Return On Assets of P7V (-5.85%) is worse than 68.49% of its industry peers.
- P7V's Return On Equity of -28.28% is on the low side compared to the rest of the industry. P7V is outperformed by 72.60% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -5.85% | ||
| ROE | -28.28% | ||
| ROIC | N/A |
ROA(3y)-2.66%
ROA(5y)-3.34%
ROE(3y)-11.76%
ROE(5y)-13.84%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- The Gross Margin of P7V (52.77%) is better than 83.56% of its industry peers.
- In the last couple of years the Gross Margin of P7V has declined.
- The Profit Margin and Operating Margin are not available for P7V so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 52.77% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.86%
GM growth 5Y-3.11%
2. Health
2.1 Basic Checks
- P7V does not have a ROIC to compare to the WACC, probably because it is not profitable.
- P7V has more shares outstanding than it did 1 year ago.
- Compared to 5 years ago, P7V has more shares outstanding
- The debt/assets ratio for P7V has been reduced compared to a year ago.
2.2 Solvency
- P7V has an Altman-Z score of 0.18. This is a bad value and indicates that P7V is not financially healthy and even has some risk of bankruptcy.
- Looking at the Altman-Z score, with a value of 0.18, P7V is doing worse than 79.45% of the companies in the same industry.
- P7V has a debt to FCF ratio of 19.42. This is a negative value and a sign of low solvency as P7V would need 19.42 years to pay back of all of its debts.
- Looking at the Debt to FCF ratio, with a value of 19.42, P7V is in line with its industry, outperforming 49.32% of the companies in the same industry.
- A Debt/Equity ratio of 2.84 is on the high side and indicates that P7V has dependencies on debt financing.
- The Debt to Equity ratio of P7V (2.84) is worse than 89.04% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.84 | ||
| Debt/FCF | 19.42 | ||
| Altman-Z | 0.18 |
ROIC/WACCN/A
WACC5.85%
2.3 Liquidity
- P7V has a Current Ratio of 1.16. This is a normal value and indicates that P7V is financially healthy and should not expect problems in meeting its short term obligations.
- P7V has a worse Current ratio (1.16) than 69.86% of its industry peers.
- A Quick Ratio of 1.06 indicates that P7V should not have too much problems paying its short term obligations.
- Looking at the Quick ratio, with a value of 1.06, P7V is in the better half of the industry, outperforming 65.75% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.16 | ||
| Quick Ratio | 1.06 |
3. Growth
3.1 Past
- The earnings per share for P7V have decreased strongly by -31.36% in the last year.
- The Revenue has grown by 23.71% in the past year. This is a very strong growth!
- Measured over the past years, P7V shows a very strong growth in Revenue. The Revenue has been growing by 24.42% on average per year.
EPS 1Y (TTM)-31.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%11.47%
Revenue 1Y (TTM)23.71%
Revenue growth 3Y35.23%
Revenue growth 5Y24.42%
Sales Q2Q%6.21%
3.2 Future
- Based on estimates for the next years, P7V will show a quite strong growth in Earnings Per Share. The EPS will grow by 13.19% on average per year.
- The Revenue is expected to grow by 13.43% on average over the next years. This is quite good.
EPS Next Y25%
EPS Next 2Y16.19%
EPS Next 3Y13.19%
EPS Next 5YN/A
Revenue Next Year18.14%
Revenue Next 2Y14.44%
Revenue Next 3Y13.43%
Revenue Next 5YN/A
3.3 Evolution
- Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for P7V. In the last year negative earnings were reported.
- Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for P7V. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
- P7V's Enterprise Value to EBITDA is on the same level as the industry average.
- 100.00% of the companies in the same industry are more expensive than P7V, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 2.93 | ||
| EV/EBITDA | 29.99 |
4.3 Compensation for Growth
- A more expensive valuation may be justified as P7V's earnings are expected to grow with 13.19% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y16.19%
EPS Next 3Y13.19%
5. Dividend
5.1 Amount
- P7V does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
PHOTON ENERGY NV / P7V.DE FAQ
What is the ChartMill fundamental rating of PHOTON ENERGY NV (P7V.DE) stock?
ChartMill assigns a fundamental rating of 3 / 10 to P7V.DE.
Can you provide the valuation status for PHOTON ENERGY NV?
ChartMill assigns a valuation rating of 2 / 10 to PHOTON ENERGY NV (P7V.DE). This can be considered as Overvalued.
Can you provide the profitability details for PHOTON ENERGY NV?
PHOTON ENERGY NV (P7V.DE) has a profitability rating of 2 / 10.
Can you provide the financial health for P7V stock?
The financial health rating of PHOTON ENERGY NV (P7V.DE) is 2 / 10.